2025-10-22 – Press Releases – www.prnewswire.com
BEIJING, Oct. 22, 2025 /PRNewswire/ — In October 2025, a partnership between Biokin—a rising star in China’s innovative pharmaceutical sector—and global pharmaceutical leader BMS triggered a $250 million milestone payment. This is believed to be the largest antibody-drug conjugate (ADC)…
